Welcome to the
On behalf of the International Organizing Committee, we are pleased to welcome you to the 7th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma. This symposium is designed to present the latest scientific and clinical advances in childhood, adolescent, and young adult NHL, NHL biopathology, NHL genomics, stem cell transplantation, immunobiology, imaging, late effects and survivorship, treatment and prognosis.
The educational content of this conference will be relevant for Medical and Pediatric Oncologists, Stem and Immune Cell Transplantation Investigators, Basic Scientists, Physicians-in-Training (Fellows/Residents/Post Docs), Radiologists, Biostatisticians, Pathologists, Oncology Nurses and other Associated Allied Health Professionals. The conference will again feature internationally-recognized speakers from a multidisciplinary, diverse group comprised of basic scientists, translational biologists and clinical investigators. The conference includes formal didactic presentations, informal discussion panels, oral abstract presentations, poster discussions and poster presentations.
We look forward to welcoming back those of you who joined us in the past, and welcome those who will be a new attendee in 2022. An exceptional program, faculty and conference venue awaits, we hope you don’t miss it!
Chairman:
Mitchell S. Cairo, MD
Chief, Pediatric Hematology, Oncology and Stem Cell Transplantation Professor of Pediatrics, Medicine, Pathology, Microbiology & Immunology and Cell Biology & Anatomy Maria Fareri Children’s Hospital Westchester Medical Center (WMC) New York Medical College
New York, NY, USA
|
Credit Designation:
The New York Medical College designates this live activity for a maximum of 19.5 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
|
Event Disclosures:
All activity faculty and planners participating in continuing medical education activities provided by New York Medical College
are expected to disclose to the audience any significant support or substantial relationship(s) with commercial entities whose
products are discussed in their presentation and/or with any commercial supporters of the activity.
In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices
discussed in their presentations.
|
